A scrapie-like unfolding intermediate of the prion protein domain PrP(121–231) induced by acidic pH
AUTOR(ES)
Hornemann, Simone
FONTE
The National Academy of Sciences
RESUMO
The infectious agent of transmissible spongiform encephalopathies is believed to consist of an oligomeric isoform, PrPSc, of the monomeric cellular prion protein, PrPC. The conversion of PrPC to PrPSc is characterized by a decrease in α-helical structure, an increase in β-sheet content, and the formation of PrPSc amyloid. Whereas the N-terminal part of PrPC comprising residues 23–120 is flexibly disordered, its C-terminal part, PrP(121–231), forms a globular domain with three α-helices and a small β-sheet. Because the segment of residues 90–231 is protease-resistant in PrPSc, it is most likely structured in the PrPSc form. The conformational change of the segment containing residues 90–120 thus constitutes the minimal structural difference between PrPC and a PrPSc monomer. To test whether PrP(121–231) is also capable to undergo conformational transitions, we analyzed its urea-dependent unfolding transitions at neutral and acidic pH. We identified an equilibrium unfolding intermediate of PrP(121–231) that is exclusively populated at acidic pH and shows spectral characteristics of a β-sheet protein. The intermediate is in rapid equilibrium with native PrP(121–231), significantly populated in the absence of urea at pH 4.0, and may have important implications for the presumed formation of PrPSc during endocytosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27576Documentos Relacionados
- Recombinant scrapie-like prion protein of 106 amino acids is soluble
- Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells
- Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
- Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.
- Species-Independent Inhibition of Abnormal Prion Protein (PrP) Formation by a Peptide Containing a Conserved PrP Sequence